Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Cash from Investing Activities Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.24%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 30.54%
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -102.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -102.74%
Dec 31, 2025 41.91%
Sep 30, 2025 -141.35%
Jun 30, 2025 -27.40%
Mar 31, 2025 -39.99%
Dec 31, 2024 -106.55%
Sep 30, 2024 29.96%
Jun 30, 2024 -28.96%
Mar 31, 2024 -42.56%
Dec 31, 2023 40.41%
Sep 30, 2023 2.95%
Jun 30, 2023 10.54%
Mar 31, 2023 14.57%
Dec 31, 2022 -29.17%
Sep 30, 2022 -29.69%
Jun 30, 2022 -9.14%
Mar 31, 2022 30.08%
Dec 31, 2021 35.79%
Sep 30, 2021 38.16%
Jun 30, 2021 44.54%
Mar 31, 2021 12.53%
Dec 31, 2020 -21.89%
Sep 30, 2020 20.14%
Jun 30, 2020 35.11%
Mar 31, 2020 -3.87%
Dec 31, 2019 13.63%
Sep 30, 2019 47.18%
Jun 30, 2019 -37.08%
Mar 31, 2019 64.01%
Dec 31, 2018 -40.02%
Sep 30, 2018 -30.45%
Jun 30, 2018 -176.53%
Mar 31, 2018 -43.66%
Dec 31, 2017 49.67%
Sep 30, 2017 -16.88%
Jun 30, 2017 -30.53%
Mar 31, 2017 -15.19%
Dec 31, 2016 -35.85%
Sep 30, 2016 -15.03%
Jun 30, 2016 34.50%
Mar 31, 2016 -401.70%
Dec 31, 2015 106.23%
Sep 30, 2015 -89.12%
Jun 30, 2015 15.18%
Mar 31, 2015 -181.88%
Dec 31, 2014 -282.93%
Sep 30, 2014 -47.06%
Jun 30, 2014 -63.96%
Mar 31, 2014 -13.96%